Norbert Riedel
Chairman bij ETON PHARMACEUTICALS, INC.
Vermogen: 4 M $ op 31-03-2024
Profiel
Norbert G.
Riedel was the founder of Aptinyx, Inc. (founded in 2015) and served as the Executive Chairman.
He currently holds the position of Chairman at Eton Pharmaceuticals, Inc. since 2017, Director at Jazz Pharmaceuticals, Inc. since 2013, Director at Illinois Biotechnology Industry Organization since 2001, Independent Director at Jazz Pharmaceuticals Plc since 2013, Director at TRACT Therapeutics, Inc., Director at Cerevel Therapeutics LLC since 2018, Lead Independent Director at Cerevel Therapeutics Holdings, Inc. since 2018, Director at Cerevel Therapeutics, Inc., Operating Partner at Beecken Petty O'Keefe & Co. LP, Trustee at Chicago Symphony Orchestra Association, Member at Osterreichische Akademie Der Wissenschaften since 2009, Member-Supervisory Board at Zytoprotec GmbH, Adjunct Professor at Feinberg School of Medicine, and Industry Advisor at Agent Capital LLC.
He has also held former positions including President, Chief Executive Officer & Director at Naurex, Inc. from 2014 to 2015, Vice Chairman-Supervisory Board at MediGene AG from 2003 to 2013, Director at Oscient Pharmaceuticals Corp.
from 1999 to 2010, Independent Director at ARIAD Pharmaceuticals, Inc. from 2011 to 2017, Director at Genencor International, Inc., Director at Illinois Biotechnology Innovation Organization, Chief Scientific & Innovation Officer at Baxter International, Inc. from 2011 to 2013, Principal at Hoechst AG, President-Recombinant Strategic Business Unit at Baxter BioScience Corp.
from 1998 to 2001, Head-Global Biotechnology at Hoechst Marion Roussel, Inc. from 1996 to 1998, and Associate Professor at Boston University School of Medicine from 1987 to 1991.
Dr. Riedel obtained his undergraduate degree and doctorate from Johann Wolfgang Goethe-Universität Frankfurt am Main in 1983.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
08-01-2024 | 42 810 ( 0.02% ) | 2 M $ | 31-03-2024 | |
14-08-2023 | 13 705 ( 0.02% ) | 2 M $ | 31-03-2024 | |
13-02-2024 | 59 745 ( 0.23% ) | 224 044 $ | 31-03-2024 | |
APTINYX INC
2.00% | 24-04-2023 | 1 355 873 ( 2.00% ) | 130 164 $ | 31-12-2023 |
Actieve functies van Norbert Riedel
Bedrijven | Functie | Begin |
---|---|---|
JAZZ PHARMACEUTICALS PLC | Director/Board Member | 13-05-2013 |
ETON PHARMACEUTICALS, INC. | Chairman | 01-11-2018 |
CEREVEL THERAPEUTICS HOLDINGS, INC. | Director/Board Member | 01-12-2018 |
Beecken Petty O'Keefe & Co. LP
Beecken Petty O'Keefe & Co. LP Investment ManagersFinance Beecken Petty O'Keefe & Co LP (BPOC) is a private equity firm founded in 1996 by Dave Beecken, Bill Petty, and Ken O’Keefe. The firm is headquartered Chicago, Illinois. | Private Equity Investor | - |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | Director/Board Member | - |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | Consultant / Advisor | - |
Feinberg School of Medicine | Corporate Officer/Principal | - |
TRACT Therapeutics, Inc.
TRACT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services TRACT Therapeutics, Inc. develops revolutionary therapeutic cells. The company was founded by Gretchen S. Johnson and Joseph R. Leventhal and is headquartered in Chicago, IL. | Director/Board Member | - |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Director/Board Member | 01-01-2013 |
░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Eerdere bekende functies van Norbert Riedel
Bedrijven | Functie | Einde |
---|---|---|
░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Norbert Riedel
Johann Wolfgang Goethe-Universität Frankfurt am Main | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 6 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
MEDIGENE AG | Health Technology |
JAZZ PHARMACEUTICALS PLC | Health Technology |
APTINYX | Health Technology |
ETON PHARMACEUTICALS, INC. | Health Technology |
CEREVEL THERAPEUTICS HOLDINGS, INC. | Health Technology |
Bedrijven in privébezit | 20 |
---|---|
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Commercial Services |
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Hoechst AG
Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | Process Industries |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Health Technology |
Beecken Petty O'Keefe & Co. LP
Beecken Petty O'Keefe & Co. LP Investment ManagersFinance Beecken Petty O'Keefe & Co LP (BPOC) is a private equity firm founded in 1996 by Dave Beecken, Bill Petty, and Ken O’Keefe. The firm is headquartered Chicago, Illinois. | Finance |
Chicago Symphony Orchestra Association
Chicago Symphony Orchestra Association Movies/EntertainmentConsumer Services The Chicago Symphony Orchestra Association operates music bands and orchestras. The non-profit company is based in Chicago, IL. | Consumer Services |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Health Technology |
Hoechst Marion Roussel, Inc. | |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Illinois Biotechnology Industry Organization, also known as ibio, is a state trade association representing the life sciences industry in Illinois. The non-profit company is based in Chicago, IL. The organization's mission is to promote, connect, and engage the life sciences community to drive discovery, transform lives through groundbreaking research, and grow the economy. The company's membership ranges from corporations to startup companies in the biopharma, medical device, and nutrition industries. The Illinois life sciences industry is recognized as a national leader, and ibio's members are committed to expanding the boundaries of science by discovering, developing, and delivering innovative and needed therapeutics and products to transform patients' lives. | Commercial Services |
Osterreichische Akademie Der Wissenschaften | |
Baxter Ventures
Baxter Ventures Investment ManagersFinance Baxter Ventures (Baxter Ventures) is a venture capital firm subsidiary of Baxter International, Inc. founded in 2011. The firm is headquartered in Deerfield, Illinois. | Finance |
Zytoprotec GmbH
Zytoprotec GmbH Pharmaceuticals: MajorHealth Technology Zytoprotec GmbH develops and manufactures drugs for peritoneal dialysis. It specializes in the research and development of its pipeline, which encompasses PD-protec, a patented-protected solution and ICO-protec, a cytoprotective PD solution to address the market for non-glucose based PD solutions. The firm focus areas encompass portfolio management, therapeutic approach, patent management and research services. The company was founded by Karl Altenhuber, Christoph Aufricht and Christian Hoenig in 2007 and is headquartered in Vienna, Austria. | Health Technology |
Austrian Academy of Sciences
Austrian Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Austrian Academy of Sciences provides humanities and social science research services. The private company is based in Vienna, Austria. | Commercial Services |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | Finance |
TRACT Therapeutics, Inc.
TRACT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services TRACT Therapeutics, Inc. develops revolutionary therapeutic cells. The company was founded by Gretchen S. Johnson and Joseph R. Leventhal and is headquartered in Chicago, IL. | Commercial Services |
Cerevel Therapeutics LLC
Cerevel Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cerevel Therapeutics LLC operates as a biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system. The company was founded in 2018 and is headquartered in Boston, MA. | Health Technology |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | Health Technology |
Illinois Biotechnology Innovation Organization |